The director's aggressive buying at current depressed levels suggests a belief the stock is undervalued. Monitor for any upcoming positive catalysts (earnings, restructuring, or strategic update) that could reverse the negative trend.
Price Chart
Executive Summary
Director Kiai Parsa made a significant open-market purchase of Medifast stock, totaling approximately $843K over a 7-day window ending August 20, 2026, with the largest single-day purchase of $487K on August 20. This insider buying cluster, representing roughly 0.65% of the company's $130M market cap, is a notable bullish signal from a board member, especially given the company's recent stock decline and negative analyst sentiment (0% bullish rating).
Key Financial Metrics
Key Facts
- Director Kiai Parsa purchased a total of approximately $843K in MED stock over a 7-day window (Aug 19-20, 2026).
- The largest single purchase was $487K on August 20, 2026, at $11.60 per share.
- Total insider purchases represent ~0.65% of MED's $130M market cap, a significant proportional signal.
- Analyst consensus is heavily bearish: 0% bullish, with 4 Sell and 1 Strong Sell ratings.
Financial Impact
Insider purchases totaling ~$843K, representing ~0.65% of market cap, a material signal from a director.
Risk Factors
- Company has 0% analyst bullish rating with 5 sell/strong sell ratings, indicating deep fundamental concerns.
- The insider buying, while significant, is from a director, not C-suite, which carries slightly less weight than a CEO/CFO purchase.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001213900-26-092479 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 8-K | $12.11 | awaiting T+5 | — | $12.49 (+3.14%) |
Oct 15, 2026 12d ago | Press Release | $12.06 $12.17 | ▲ +0.91% | ▲ +1.93% | $12.49 (+3.57%) |
Oct 6, 2026 21d ago | Press Release | $11.51 $11.67 | ▲ +1.39% | ▲ +1.53% | $12.49 (+8.51%) |
Oct 1, 2026 26d ago | Press Release | $11.43 $11.43 | · 0.00% | ▼ −1.30% | $12.49 (+9.27%) |
Aug 28, 2026 8w ago | Insider Buy | $12.18 $12.63 | ▲ +3.69% | ▲ +3.59% | $12.49 (+2.55%) |
Aug 26, 2026 8w ago | Insider Buy | $12.22 $12.67 | ▲ +3.68% | ▲ +3.80% | $12.49 (+2.21%) |
Aug 21, 2026 9w ago | Insider Buy | $11.95 $12.18 | ▲ +1.92% | ▲ +1.45% | $12.49 (+4.52%) |
Jul 17, 2026 14w ago | 8-K | $10.26 $9.45 | ▼ −7.89% | ▼ −7.21% | $12.49 (+21.73%) |
Jun 1, 2026 21w ago | 8-K | $12.70 $12.10 | ▼ −4.72% | ▼ −1.97% | $12.49 (−1.65%) |
May 26, 2026 22w ago | 8-K | $12.72 $12.36 | ▼ −2.83% | ▼ −4.04% | $12.49 (−1.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers